XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Convertible Senior Notes Due 2022
Convertible Senior Notes Due 2026
Common Stock
Common Stock
Convertible Senior Notes Due 2022
Additional Paid-in Capital
Additional Paid-in Capital
Convertible Senior Notes Due 2022
Additional Paid-in Capital
Convertible Senior Notes Due 2026
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2019 $ 220,312     $ 34   $ 425,945     $ (199,920) $ (5,747)
Beginning Balance, shares at Dec. 31, 2019       33,848,627            
Issuance of common stock in connection with acquisition 30,434         30,434        
Issuance of common stock in connection with acquisition, shares       301,941            
Stock-based compensation 10,368         10,368        
Vesting of restricted stock units and performance-based restricted stock units, shares       44,606            
Restricted stock units and performance-based restricted stock units withheld to settle employee tax withholding liability (400)         (400)        
Restricted stock units and performance-based restricted stock units withheld to settle employee tax withholding liability, shares       (4,483)            
Exercise of stock options 2,989         2,989        
Exercise of stock options, shares       126,374            
Issuance of shares under employee stock purchase plan 1,710         1,710        
Issuance of shares under employee stock purchase plan, shares       30,943            
Other comprehensive loss (6,520)                 (6,520)
Net loss (25,385)               (25,385)  
Balance at Mar. 31, 2020 233,508     $ 34   471,046     (225,305) (12,267)
Ending Balance, shares at Mar. 31, 2020       34,348,008            
Balance at Dec. 31, 2020 252,305     $ 35   542,776     (293,316) 2,810
Beginning Balance, shares at Dec. 31, 2020       35,449,447            
Issuance of common stock in connection with acquisition 23,032         23,032        
Issuance of common stock in connection with acquisition, shares       162,820            
Stock-based compensation 12,770         12,770        
Vesting of restricted stock units and performance-based restricted stock units 1     $ 1            
Vesting of restricted stock units and performance-based restricted stock units, shares       64,304            
Restricted stock units and performance-based restricted stock units withheld to settle employee tax withholding liability (1,611)         (1,611)        
Restricted stock units and performance-based restricted stock units withheld to settle employee tax withholding liability, shares       (11,649)            
Exercise of stock options $ 1,604         1,604        
Exercise of stock options, shares 52,955     52,955            
Issuance of shares under employee stock purchase plan $ 2,451         2,451        
Issuance of shares under employee stock purchase plan, shares       23,499            
Equity component of convertible notes due 2026, net of allocated issuance costs and taxes     $ 99,000         $ 99,000    
Purchase of capped call hedge for the convertible notes due 2026, including issuance costs     $ (35,124)         $ (35,124)    
Equity component of settlement of convertible notes due 2022   $ 15,652     $ 2   $ 15,650      
Equity component of settlement of convertible notes due 2022, shares         1,870,823          
Termination and modification of capped call hedge for convertible notes due 2022   $ 10,886         $ 10,886      
Other comprehensive loss (2,597)                 (2,597)
Net loss (21,789)               (21,789)  
Balance at Mar. 31, 2021 $ 356,580     $ 38   $ 671,434     $ (315,105) $ 213
Ending Balance, shares at Mar. 31, 2021       37,612,199